Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study Xiumei Jiang; Pan Wang; Ke Su; Han Li; Hao Chi; Fei Wang; Yu Liu; Ke Xu;

From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America. Federico Piñero; Ezequiel Mauro; Paola Casciato; Alejandro Forner;

Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: A systematic review and meta-analysis Jiali Chen; Kun He; Yunwei Han; Lu Guo; Ke Su; Zhenying Wu;